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SINGLE AND MULTIPLE PULSES OF GROWTH HORMONE (GH) I N THE TREATMENT OF GH DEFICIENCY
We have compared subcutaneous (s.c.) p u l s e d a d m i n i s t r a t i o n of hGH 0.6 I U 3 h o u r l y a t n i g h t w i t h hGH 2 I U a d m i n i s t e r e d s . c . and 4 I U a d m i n i s t e r e d i.m. i n 6 GH d e f i c i e n t c h i l d r e n aged 5.9-11.6 y e a r s . F i v e had r e c e i v e d hGH 4 I U i.m. f o r 3.6 y e a r s ( r a n g e 2.5-4).
Zach of t h e s e c h i l d r e n and one new p a t i e n t r e c e i v e d hGH 2 IU s . c . and 0 . 6 I U 3 t i m e s each n i g h t v i a a mini i n f u s i o n pump f o r 6 months i n random o r d e r . Serum GH p r o f i l e s were o b t a i n e d on a l l t r e a t m e n t regimens.
Peak GH c o n c e n t r a t i o n s and a r e a s under t h e GH c u r v e s were dose r e l a t e d . The time t o a t t a i n t h e GH peaks was s i m i l a r u s i n g i.m. (3.6h) o r s . c . (3.9h) r o u t e s . A s i n g l e i n j e c t i o n d i d n o t mimic p h y s i o l o g i c a l GH p u l s e s b u t t h e s e were more c l o s e l y a t t a i n e d u s i n g p u l s e d a d m i n i s t r a t i o n .
Four c h i l d r e n completed t h e e n t i r e s t u d y ; 3 grew e q u a l l y a t a l l t i m e s b u t h e i g h t v e l o c i t y f e l l i n one on t h e p u l s e d regimen. Following c e s s a t i o n of a l l GH t r e a t m e n t , mean h e i g h t v e l o c i t y SDS (-4.0) was s i g n i f i c a n t l y lower t h a n b e f o r e a l l t r e a t m e n t s (-2.1). P u l s a t i l e hGH a d m i n i s t r a t i o n i s e f f e c t i v e b u t had no s i g n i f i c a n t advantage. A p o s t t r e a t m e n t v e l o c i t y must n o t be used t o measure t h e e f f e c t s of a t r e a t m e n t . The aim of t h i s study was t h e evaluation of final height i n patients t r e a t e d with GH and t o examine whether any auxological, hormonal o r therapeutic f a c t o r s have a significant influence on t h e result. 22 patients with idiopathic t o t a l G H deficiency were studied, 8 had isolated GH deficiency, 1 4 had various additional pituitary deficiencies. A t t h e onset of t r e a t m e n t CA was 10,124 yrs (x 2 SD), BA -4,7 +1,8 SDS, height -4,7+1,2 SDSCA and -0,54+1,5 SDS . Duration of GH therapy was 6,623 yrs, t h e average weekly 3 o s e wa&?$,l + 2,D U. Final height was significantly corr e l a t e d with t a r g e t height (p<0,001). If final height was expressed in SDS of t a r g e t height, t h e r e was a significant correlation with t h e height SDS (p<D,01) a t t h e onset of therapy. No correlation between final hei& and height SDS ,CA, BA, weight SDS for height, respectively a t t h e onset of treatmenEAor stimulated G H levels, serum SM-C, growth velocity during t h e first year or GH dose o r duration of Gtl t r e a t m e n t could b e found. In addition, patients were arbitrarily classified i n t w o groups, one with a mean final height of -1,3+0,8 CJDS (n.12, group A) and one with final height of -3,7+0,6 SDSCA (n.10, g&tp B). The groups did not differ i n any of t h e encountered parameters. However, i n group A 9/12 patients (vs.l/lO i n group B) had additional gonadotropin deficiency (p<0,01). In conclusion, parental height and height f o r BA a t t h e onset of t r e a t m e n t s e e m s t o have an influence of final height. Patients with additional gonadotropin deficiency had a b e t t e r prognosis.
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ASSOCIATEE WITH MICWPENIS: A "TRANSITORY A N D R X a INSENSITMTY SWIMME ?"
A n w e n r e c e p t o r a n a l y s e s o f scrota1 s k i n fran a
b o y w i t h cGH-D a s s o c i a t e d w i t h m i c r o p e n i s , d o n e a t a g e 1 a n d 3 yrs, r e s p e c t i v e l y , revealed d e c r e a s e d cytosolic b i n d i n g for t e s t o s t e r o n e ( T ) and d i h y d r o t e s t o s t e r o n e ( N ) ,
ccrnpared t o a g e matched controls. R i s e s in serun a n d r o g e n s (OF) a f t e r 2.dXistlmulation as w e l l as androgen-5a-reductase (A5R) activities were also e v a l u a t e d a t both ases. S t r e t c h e d penile length was 1.1 m i to 3.2 an (P25) a t a g e 3. body l e n q t h follmed the P 3 u n d e r t r e a t m e n t w i t h s y n t h e t i c GH. The r e c e p t o r a d A5R d a t a are in a g r e e n e n t w i t h the d w e l o p n e n t o f the external g e n i t a l s t a t u s a n d indicate a "catch-up" g r 
I n o r d e r t o s t u d y s t r u c t u r e f u n c t l o n r e l a t l o n s h l p s o f t h e p i t u i t a r y i n growth hormone d e f l c l e n c y (HGD) high resolution computer a s s i s t e d tomography (HR-CAT) was performed i n 24 consecutive c h l l d r e n w i t h l d l o p a t h i c GHD. The p o p u l a t i o n s t u d l e d was c h a r a c t e r i s e d t h u s : 11 male, 1 3 female; age range newborn t o 1 5 y e a r s ; 1 5 i s o l a t e d GHD, 9 mult-iple p i t u l t a r y hormone d e f l c l e~~o y (MPHD); 17 s p o r a d i c and 7 f a m l l i a l GHD; 11 had recorded a d v e r s e p e r i n a t a l e v e n t s ( b r e e c h o r f o r c e p s d e l i v e r y , a s p h y x i a , e x c e s s i v e b r u i s i n g , s u r f a c t a n t d e f l c l e n c y , exchange transfusion, u m b l l l c a l haemorrhage and n e o n a t a l f i t s ) ; 19 had i v growth hormone r e l e a s i n g f a c t o r t e s t s (~P -G R F~-~~) a t diagnosis.
HR-CAT s c a n s showed 1 3 c h l l d r e n t o have an empt.y s e l l a and 3 w l t h a partially empty s e l l a -Group 1 ; and 8 w1t.h a f u l l s e l l a -
Group
11.
No d i f f e r e n c e bet.ween Group I and I 1 was found w1t.h r e s p e c t t o : Age, s e x o r auxology a t presentation; l s o l a t e d GtID o r MPHD; s p o r a d i c o r f a m l l l a l GHD; growth hormone r e s p o n s e t o GRF. However, p e r i n a t a l a d v e r s e e v e n t s were s t r o n g l y a s s o c l a l e t l w i t h Group I ( p = 0.02). 
The present. f i n d i n g s support. t h e concept t h a t a d v e r s e p e r l~i a t . a l e v e n t s a r e a major f a c t o r I n t h e a e t i o l o g y o f GHD
HEAD AND BODY MEASUREMENTS IN PATIENTS WITH IDIOPATHIC GROWTH HORMONE DEFICIENCY IIGHOI
In a previous anthropometric study. Zachman e t al. 119801 showed that GH deficient children had characteristic differences in cranial proportions and less retardation in head growth compared t o s t a t u r e and other body dimensions.
To extend these results 15 head and 12 body measurements were taken on 0 3 patients [27 girls of mean bone a g e 1.5 -11.0 "years". mean 6.0 "years": 56 boys of mean bone age 1.0 -13.5 "years". mean 5.1 "years" with isolated GH deficiency. These were compared with a large population of normal Polish children of the s a m e a g e or height. All measurements were expressed a s standard deviation scores ISDSI. The mean s t a t u r e of the girls was -4.8 + 1.2 SDS and f o r boys -4.0 + 1.0 SOS.
Our d a t a showed t h a t all f a c e measurements. along with occipital breadth. were disproportionately small in t h e GH deficient children compared t o children of t h e s a m e height. In contrast head breadth. length end circumference were not different although forehead breadth tended to be greater. There was no disproportion between head breadth and length.
In girls only. t h e mean biacromial SDS was significantly less than that f o r biiliocristal diameter.
We conclude that growth of t h e bones of t h e f a c e and the skull base it more retarded than that of the cranial vault or long bones which gives rise t o the classical clinical facial characteristics of the GH deficient child.
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2nd Pediatric Clinic, Universityof Bologna, Italy EXAHINATION OF T H E AUXOLOGI CAL AND HORMONAL PARAMETERS I N 1001' SHORT NORMAL" RE: DIAGNOSIS OF "SUSPECTED GH DEFICIENCY". 100 subjects, 3rd percentile for height, uere submitted to three tests; sleep (8 pm-7.30 am). arginine and L-dopa. Patients: 75 males (a. 5.7/16.2), 25 females (a. 4.8/14.1). All subjects had a normal peak >8ng/m1 in the sleep test. 24 had a normal peak in 1 pharmacological test (group A), I3 had a norm. peak in 2 pharnac. tests (group 8) and 63 had no peak in 2 pharmac. tests (group C ) . In puberty the percentage of group A and 8 was signific.higher than in prepuberty. The 3 groups were compared as regards growth and endocrinological data (height SDS, bone age, bone age SDS, height velocity SDS, GH Hx peak and area in sleep test, S m C 8 a m and 8 pm). All the data uere similar except HV SDS, lower in group C ( P (0.05 vs 8, R( 0.01 vs A ) . If patients are separated as S m C 8 am (dOth perc. or)lOth perc. f o r age; our data for normality). the percentage of 3 groups is similar in two ranges of SnC. There uas no correlation between data of sleep test and data of pharmacological tests. The examination of GH in sleep test (peak mx. area), indicated: 1) mx peak uas higher in prepubertal males (P<0.05), and in these the area was higher in subjects without bone age delay(Pc0.001); 2 ) the data of subjects with GH area <mean -1 S D were similar to the subjects uith areasmean +I SO; 3 ) no correlation between GI! area and SmC (correlation SmC-bone age was excluded). The examination of SmC indicated: I ) SmC is correlated with bone age only in males (P 20.025); 2) SmC is higher in puberty (Pc0.05); 3) Pubertal males uith SmC (10th p e r c . have lower a r e a than subjects uith SmC >loth p e r c . (Pt0.05);
